Valuation Astal Laboratories Limited

Stocks

Market Closed - Bombay S.E. 14:02:22 14/08/2026 +04			5-day change	1st Jan Change
86.19 ^INR	-2.37%		+6.03%	-0.76%

08-14	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	36.52	34.77	64.34	118.1	401.9	747.2
Change	-	-4.79%	85.03%	83.54%	240.29%	85.93%
Enterprise Value (EV) ¹	36.38	34.46	64.16	117.2	344.2	862.6
Change	-	-5.27%	86.18%	82.75%	193.57%	150.59%
P/E	-130x	577x	-376x	722x	26.3x	9.45x
PBR	0.71x	0.67x	1.25x	2.27x	1.72x	2.08x
PEG	-	-5x	1x	-4x	0x	0x
Capitalization / Revenue	18.1x	17.2x	30.5x	3.27x	1.7x	1.17x
EV / Revenue	18x	17.1x	30.4x	3.25x	1.45x	1.36x
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0708	0.0152	-0.0431	0.041	1.554	8.043
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.019	2.019	2.108	36.07	236.6	636.6
EBITDA	-	-	-	-	-	-
EBIT	-	-	-	-	-	-
Net income ¹	-0.2815	0.0602	-0.1711	0.164	7.847	89.25
Net Debt ¹	-0.1448	-0.3129	-0.1828	-0.844	-57.64	115.4
Reference price ²	9.19	8.75	16.19	29.60	40.88	76.01
Nbr of stocks (in thousands)	3,974	3,974	3,974	3,990	9,830	9,830
Announcement Date	10/09/20	01/09/21	08/09/22	25/08/23	12/07/24	18/08/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTAL LABORATORIES LIMITED	-	-	-	-	39.38M
ELI LILLY AND COMPANY	33.51x	12.18x	24.85x	0.59%	1,052B
JOHNSON & JOHNSON	28.96x	-	-	2.06%	627B
ABBVIE INC.	31.84x	7.42x	15.42x	2.75%	441B
ROCHE HOLDING AG	19.79x	4.7x	11.65x	2.81%	349B
NOVARTIS AG	21.42x	5.55x	13.86x	2.89%	287B
ASTRAZENECA PLC	19.89x	4.11x	11.68x	2.14%	241B
AMGEN INC.	26.26x	6.84x	12.14x	2.43%	224B
NOVO NORDISK A/S	13.32x	4.79x	9.96x	3.83%	202B
GILEAD SCIENCES, INC.	-42.28x	6.13x	23.96x	2.38%	172B
Average	16.97x	6.47x	15.44x	2.43%	359.52B
Weighted average by Cap.	24.10x	8.04x	17.74x	2%